Description: Sigyn Therapeutics, Inc. operates as a therapeutic technology company that treats inflammatory conditions by cytokine storm syndrome. It offers Sigyn Therapy, a blood purification technology designed to mitigate cytokine storm syndrome through the broad-spectrum depletion of inflammatory targets from the bloodstream. Sigyn Therapeutics, Inc. was incorporated in 2019 and is based in San Diego, California.
Home Page: www.sigyntherapeutics.com
2468 Historic Decatur Road
San Diego,
CA
92106
United States
Phone:
619 353 0800
Officers
Name | Title |
---|---|
Mr. James A. Joyce Ph.D. | Co-founder, Chairman & CEO Inventor |
Mr. Craig P. Roberts | Co-founder, CTO & Director |
Mr. Gerald DeCiccio C.P.A., M.B.A. | Chief Financial Officer |
Ms. Charlene R. Owen | Director of Operations |
Dr. Annette Marleau Ph.D. | Chief Scientific Officer |
Exchange: OTCQB
Country: US : United States of America
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Biotechnology |
GIC Sub-Industry: | Biotechnology |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 39.0415 |
Price-to-Sales TTM: | 114.9523 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 5 |